Finance

Lists
NATCOPHARM:NSE
Natco Pharma Ltd
800,00 ₹
+1,34%
(+10,60) 1D
12 қаз., 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for NATCOPHARM...
Open
789,40 ₹
High
804,75 ₹
Low
789,40 ₹
Mkt. cap
156,93 млрд
Avg. vol.
436,28 м.
Volume
501,24 м.
Dividend
0,56%
Quarterly dividend
1,12 ₹
Ex-dividend date
2026 ж. 20 там.
P/E ratio
12,62
52-wk high
1 216,89 ₹
52-wk low
785,65 ₹
EPS
63,37 ₹
Shares outstanding
182,26 млн
No. of employees
4 мың
Open
789,40 ₹
High
804,75 ₹
Low
789,40 ₹
Mkt. cap
156,93 млрд
Avg. vol.
436,28 м.
Volume
501,24 м.
Dividend
0,56%
Quarterly dividend
1,12 ₹
Ex-dividend date
2026 ж. 20 там.
P/E ratio
12,62
52-wk high
1 216,89 ₹
52-wk low
785,65 ₹
EPS
63,37 ₹
Shares outstanding
182,26 млн
No. of employees
4 мың
News stories
From web sources and news partners
Profile
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
About Natco Pharma Ltd
CEORajeev Nannapaneni
Employees4,43 мың
Founded1981
HeadquartersBanjara Hills, Телингана, Үндістан
SectorPharmaceutical industry
Last report
2026 ж. 14 там.
Fiscal period
Q1 2027
11,53 ₹ / 8,86 ₹
+30,06%beat
Revenue / Est. (INR)
7,35 млрд / 7,96 млрд
-7,66%miss
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
13,63 млрд
6,47 млрд
7,43 млрд
7,35 млрд
Cost of goods sold
1,70 млрд
1,33 млрд
1,99 млрд
1,48 млрд
Cost of revenue
1,70 млрд
1,33 млрд
1,99 млрд
1,48 млрд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,00 млрд
1,59 млрд
1,63 млрд
1,79 млрд
Operating expense
6,66 млрд
4,02 млрд
4,38 млрд
4,48 млрд
Total operating expenses
8,36 млрд
5,35 млрд
6,37 млрд
5,96 млрд
Operating income
5,27 млрд
1,12 млрд
1,06 млрд
1,39 млрд
Other non operating income
1,00 млрд
581,00 млн
-2,11 млрд
592,00 млн
EBT including unusual items
6,14 млрд
1,72 млрд
1,80 млрд
2,70 млрд
EBT excluding unusual items
6,14 млрд
1,72 млрд
2,02 млрд
2,70 млрд
Income tax expense
958,00 млн
207,00 млн
-892,00 млн
634,00 млн
Effective tax rate
15,61%
12,03%
-49,61%
23,49%
Other operating expenses
4,14 млрд
1,96 млрд
2,23 млрд
2,22 млрд
Net income
5,18 млрд
1,52 млрд
2,68 млрд
2,06 млрд
Net profit margin
38,03%
23,40%
36,08%
28,09%
Earnings per share
28,94
8,46
14,96
11,53
Interest and investment income
-
-
2,33 млрд
-
Interest expense
-131,00 млн
-95,00 млн
-
-130,00 млн
Net interest expenses
-131,00 млн
-95,00 млн
2,33 млрд
-130,00 млн
Depreciation and amortization charges
524,00 млн
462,00 млн
504,00 млн
471,00 млн
EBITDA
5,82 млрд
1,57 млрд
1,55 млрд
1,91 млрд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары